Multidrug-resistant Gram-negative bacterial infections

2025/01/01 by Nenad Maćešić, Nenad Macesic, Anne‐Catrin Uhlemann +3 · 2 voices · 32 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Antibiotic Resistance in Bacteria #Antibiotics #Bacteria #Bacterial Identification and Susceptibility Testing #Biology #Escherichia coli #Escherichia coli research studies #Genetics #Gram #Gram-negative bacteria #Gram-negative bacterial infections #Medicine #Microbiology #Multiple drug resistance

paper · doi:10.1016/s0140-6736(24)02081-6

openalex publication_date 2025/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06

Cited by

• Genetic Dissection of Cyclic di‐ GMP Signalling in Pseudomonas aeruginosa via Systematic Diguanylate Cyclase Disruption
• Molecular characterization of β-lactamase genes and porin alterations in multidrug-resistant Gram-negative clinical isolates from Calabria, Southern Italy
• From antibiotic to peptide siderophore conjugates as modular strategies against multidrug-resistant bacteria
• Carbapenemases: epidemiology, detection and management in a changing global landscape
• Climate change and antimicrobial resistance
• Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an update
• Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis
• Genetic Dissection of Cyclic di-GMP Signalling in Pseudomonas aeruginosa via Systematic Diguanylate Cyclase Disruption. [europepmc]
• Prevalence and Associated Mortality of Infections by Multidrug-Resistant Organisms in Pediatric Intensive Care Units in Argentina (PREV-AR-P). [europepmc]
• Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship. [europepmc]
• Restoring Control: Real-World Success with Imipenem-Relebactam in Critical MDR Infections-A Multicenter Observational Study. [europepmc]
• Efflux-Mediated Resistance in Enterobacteriaceae : Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. [europepmc]
• Gut microbiota dysbiosis and systemic immune dysfunction in critical ill patients with multidrug-resistant bacterial colonization and infection. [europepmc]
• Assessing the Mechanism of Action of Synthetic Nanoengineered Antimicrobial Polymers against the Bacterial Membrane of Pseudomonas aeruginosa . [europepmc]
• Multidrug-Resistant Escherichia coli Associated with Respiratory and Systemic Infection in a Domestic Rabbit in Romania: First Confirmed Case. [europepmc]
• Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance. [europepmc]
• Clinical performance of the VITEK REVEAL fast antimicrobial susceptibility test within a real-world workflow for gram-negative bacteremia: comparison with QMAC-dRAST and conventional methods. [europepmc]
• Rapid Molecular Diagnostics for MDR Nosocomial Infections in ICUs: Integration with Prevention, Stewardship, and Novel Therapies. [europepmc]
• An Enzyme-Like Catalyzed Nanosheets for Redox Stress Oscillation Therapy Against Bacterial Infections. [europepmc]
• Iron/Cobalt Dual-Atom Catalyst Orchestrate Photothermal-Chemodynamic Immunotherapy Against MRSA: Multi-Omics Dissection in Murine and Porcine Models. [europepmc]
• Efficacy of ceftazidime/avibactam versus other antimicrobial agents for treating multidrug- resistant Pseudomonas aeruginosa : a propensity-matched retrospective analysis. [europepmc]
• A novel generative framework for designing pathogen-targeted antimicrobial peptides with programmable physicochemical properties. [europepmc]
• Recent Developments on Coumarin Hybrids as Antimicrobial Agents. [europepmc]
• How do immunometabolites shape bacterial infections? [europepmc]
• Management of infections caused by carbapenemase-producing Enterobacterales in France: a real-world study. [europepmc]
• Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams? [europepmc]
• GLP-1RA Liraglutide Attenuates Sepsis by Modulating Gut Microbiota and Associated Metabolites. [europepmc]
• AMR-GNN: a multi-representation graph neural network framework to enable genomic antimicrobial resistance prediction. [europepmc]
• GC-MS profiling and antivirulence potential of limonene-rich Citrus medica cv. 'Rugosa' essential oil: in vitro and in silico evaluations. [europepmc]
• Glyphosate resistance as a potential driver for the dissemination of multidrug-resistant clinical strains. [europepmc]
• Cultured microbial community complexity is associated with antimicrobial resistance and Enterobacterales enrichment in adult odontogenic infections. [europepmc]
• Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and other WHO priority pathogens, including Candida auris. [europepmc]

Discussions

• #IDSky #MedSky required reading: Multidrug-resistant Gram-negative bacterial infections Nenad Macesic, Anne-Catrin Uhlemann, Anton Peleg Review in @thelancet.bsky.social doi.org/10.1016/S014... [bsky, 84 points, 4 comments]
• Summary of new antibiotic agents for the treatment of MDR Gram negative bacterial infections doi.org/10.1016/S014... #IDSky [bsky, 29 points, 4 comments]